HR 10544 Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
To modernize and strengthen Federal efforts to improve ovarian cancer awareness, hereditary cancer risk assessment, access to genetic counseling and testing, and access to specialty care, and for other purposes.
Referred to
Sponsor (1)
-
![Rep. DeLauro, Rosa L. [D-CT-3]](https://media.civicgate.org/people/d/politicians/D000216.thumb.jpg)
Rep. DeLauro, Rosa L. (D-CT) [#3]
1 cosponsor
-
![Rep. Bacon, Don [R-NE-2]](https://media.civicgate.org/people/d/politicians/B001298.thumb.jpg)
Rep. Bacon, Don (R-NE) [#2]
Money behind the sponsor
Top reported contributors to Rosa L. Delauro’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.
- YALE UNIVERSITY $13,483
- RTX $10,800
- CRD ASSOCIATES $10,300
- Employer not reported $8,800
- ARNOLD & PORTER $7,300
Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for Rosa L. Delauro → · Outside spending →
Actions (2)
- Sep 24, 2026 Referred to the House Committee on Energy and Commerce. · house
- Sep 24, 2026 Introduced in House
Full text
The full text may not be published yet. CivicGate retrieves it automatically once it appears — or check now (it also files the committees and issues).
Comments